Stock Scorecard
Stock Summary for Embecta Corp (EMBC) - $3.29 as of 7/27/2026 10:53:47 AM EST
Total Score
19 out of 30
Safety Score
34 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for EMBC
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for EMBC
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for EMBC
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for EMBC
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for EMBC (34 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 7 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 0 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 2 |
| Operating Margin (Max of 10) | 4 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 10 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for EMBC
Financial Details for EMBC
Company Overview |
|
|---|---|
| Ticker | EMBC |
| Company Name | Embecta Corp |
| Country | USA |
| Description | Embecta Corp (EMBC) is a leading medical technology company specializing in innovative insulin delivery systems aimed at enhancing diabetes management. Born from a spin-off of Becton, Dickinson and Company, Embecta provides a comprehensive portfolio of advanced products, including cutting-edge insulin pens and syringes tailored to improve patient outcomes. With a robust focus on operational excellence and customer satisfaction, Embecta is well-positioned to capitalize on growth opportunities in the rapidly expanding diabetes care market, strengthening its leadership in this vital sector. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL INSTRUMENTS & SUPPLIES |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 8/14/2026 |
Stock Price History |
|
| Last Day Price | 3.29 |
| Price 4 Years Ago | 22.15 |
| Last Day Price Updated | 7/27/2026 10:53:47 AM EST |
| Last Day Volume | 737,380 |
| Average Daily Volume | 2,110,247 |
| 52-Week High | 15.08 |
| 52-Week Low | 2.76 |
| Last Price to 52 Week Low | 19.20% |
Valuation Measures |
|
| Trailing PE | 1.74 |
| Industry PE | 190.89 |
| Sector PE | 88.41 |
| 5-Year Average PE | 4.00 |
| Free Cash Flow Ratio | 1.05 |
| Industry Free Cash Flow Ratio | 26.20 |
| Sector Free Cash Flow Ratio | 29.81 |
| Current Ratio Most Recent Quarter | 2.46 |
| Total Cash Per Share | 3.12 |
| Book Value Per Share Most Recent Quarter | -10.55 |
| Price to Book Ratio | 2.61 |
| Industry Price to Book Ratio | 3.36 |
| Sector Price to Book Ratio | 11.88 |
| Price to Sales Ratio Twelve Trailing Months | 0.19 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.88 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.99 |
| Analyst Buy Ratings | 0 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 59,328,000 |
| Market Capitalization | 195,189,120 |
| Institutional Ownership | 99.49% |
Dividends |
|
| Ex-Dividend Date | 5/28/2026 |
| Previous Dividend Amount | 0.1500 |
| Current Dividend Amount | 0.0100 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.46 |
| Trailing Annual Dividend Yield | 14.15% |
| Forward Annual Dividend Rate | 0.04 |
| Forward Annual Dividend Yield | 1.23% |
| 5-Year Dividend Payments Count | 16 |
| 3-Year Average Dividend Yield | 5.14% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | -93.33% |
| 3-Year Dividend Growth Rate Percentage | -74.18% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | 24.34% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 82.70% |
| Annual Earnings Growth | 21.84% |
| Reported EPS 12 Trailing Months | 1.89 |
| Reported EPS Past Year | 0.98 |
| Reported EPS Prior Year | 2.97 |
| Net Income Twelve Trailing Months | 111,900,000 |
| Net Income Past Year | 95,400,000 |
| Net Income Prior Year | 78,300,000 |
| Quarterly Revenue Growth YOY | -14.40% |
| 5-Year Revenue Growth | -0.09% |
| Operating Margin Twelve Trailing Months | 19.30% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 184,900,000 |
| Total Cash Past Year | 225,500,000 |
| Total Cash Prior Year | 267,500,000 |
| Net Cash Position Most Recent Quarter | -1,132,000,000 |
| Net Cash Position Past Year | -1,163,200,000 |
| Long Term Debt Past Year | 1,388,700,000 |
| Long Term Debt Prior Year | 1,565,300,000 |
| Total Debt Most Recent Quarter | 1,316,900,000 |
| Equity to Debt Ratio Past Year | -0.88 |
| Equity to Debt Ratio Most Recent Quarter | -0.91 |
| Total Stockholder Equity Past Year | -651,200,000 |
| Total Stockholder Equity Prior Year | -738,300,000 |
| Total Stockholder Equity Most Recent Quarter | -626,100,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 204,700,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 3.45 |
| Free Cash Flow Past Year | 182,400,000 |
| Free Cash Flow Prior Year | 19,900,000 |
Options |
|
| Put/Call Ratio | 0.11 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.07 |
| MACD Signal | -0.12 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.81 |
| RSI | 0.00 |
| 50-Day SMA | 9.84 |
| 150-Day SMA | 12.14 |
| 200-Day SMA | 15.04 |
System |
|
| Modified | 7/27/2026 10:31:04 PM EST |